TEST 2019-nCoV-IgG/igM

Rapid test for the diagnosis of Covid-19

WM Capital, a company listed on AIM Italia specialized in Business Format Franchising, has received a mandate from the Chinese company Nanchino Vazyme Medical Technology Co., Ltd, with a production capacity of 500,000 daily kits, for the distribution of the analysis kit in Europe 2019- nCoV IgG / IgM Detection Kit for the diagnosis of Covid-19. Read press release>

This test uses colloidal gold immuno chromatography to detect the presence of Coronavirus IgG / IgM antibodies and detects positivity in 10 minutes, with specificity and sensitivity at 90%.
The kit has received the CE marking and has been registered in the database of the Ministry of Health to be marketed also in Italy.

It can only be made by healthcare professionals.